Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers
Open Access
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 13 (4) , 395-403
- https://doi.org/10.1111/j.1469-0691.2007.01662.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003International Journal of Infectious Diseases, 2006
- LEPTOSPIROSIS: THE NEED FOR CLINICAL RESEARCHThe American Journal of Tropical Medicine and Hygiene, 2005
- Leptospirosis: a zoonotic disease of global importancePublished by Elsevier ,2003
- Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humansVaccine, 2002
- LeptospirosisClinical Microbiology Reviews, 2001
- Les facteurs de risque de leptospirose en France : une étude cas-témoins nationale (1999)Medecine Et Maladies Infectieuses, 2001
- Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus SubcutaneousClinical Infectious Diseases, 2001
- Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trialBMJ, 2000
- Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humansMicrobes and Infection, 2000
- Subcutaneous versus intramuscular injection for booster DT vaccination of adolescentsVaccine, 1999